SELL and breast cancer: Functional experiments showed that A2M-AS1 enhances breast cancer cell proliferation, invasion, and migration, and bioinformatics analysis showed that A2M-AS1 potentially regulates cell adhesion molecule pathway members, including CD2, CD8A, and SELL.